248 related articles for article (PubMed ID: 26214308)
1. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
Kumar A; Rimando AM; Levenson AS
Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
Levenson AS
Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
Kumar A; D'silva M; Dholakia K; Levenson AS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
[TBL] [Abstract][Full Text] [Related]
7. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
[TBL] [Abstract][Full Text] [Related]
8. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
[TBL] [Abstract][Full Text] [Related]
9. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
13. Dietary stilbenes as modulators of specific miRNAs in prostate cancer.
Levenson AS
Front Pharmacol; 2022; 13():970280. PubMed ID: 36091792
[TBL] [Abstract][Full Text] [Related]
14. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
Levenson AS; Kumar A; Zhang X
Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol and prostate cancer: promising role for microRNAs.
Dhar S; Hicks C; Levenson AS
Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.
Farooqi AA; Khalid S; Ahmad A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495357
[TBL] [Abstract][Full Text] [Related]
17. The Role of Resveratrol in Cancer Therapy.
Ko JH; Sethi G; Um JY; Shanmugam MK; Arfuso F; Kumar AP; Bishayee A; Ahn KS
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194365
[No Abstract] [Full Text] [Related]
18. Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Lee PS; Chiou YS; Ho CT; Pan MH
Biofactors; 2018 Jan; 44(1):26-35. PubMed ID: 29220106
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
20. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
